Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Apricus Biosciences grants Bracco rights to market Vitaros in Italy

Jan. 3, 2011

Isotechnika and Paladin seek Canadian marketing approval for Voclera

Dec. 22, 2010

Health Canada approves velaglucerase alfa for type I Gaucher's disease

Dec. 2, 2010

Health Canada approves Allergan's Restasis for dry eye disease

Nov. 26, 2010

Health Canada approves Vitaros as first-line therapy for erectile dysfunction

Nov. 16, 2010

Medicago's H5N1 avian flu vaccine approved to enter phase II trial

Nov. 4, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...